Breast cancer-related lymphedema
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. (Qualitative) Patients: (1) Clinically diagnosed with breast cancer-related secondary lymphedema; (2) Aged 18 or older, capable of expressing themselves independently; (3) Normal language abilities, able to cooperate with interviews, and willing to sign informed consent; (4) Received comprehensive decongestive therapy within the past year. 2. Family members: (1) Aged 18 or older, without severe visual or hearing impairments; (2) Living with the patient for a long period; (3) Fully understand the study and voluntarily agree to participate. 3. (Intervention) Patients: (1) Clinically diagnosed with breast cancer-related secondary lymphedema and currently receiving comprehensive swelling reduction treatment; (2) Aged 18 or above, with at least primary school education and basic reading ability; (3) Able to cooperate with questionnaire completion and intervention measures, and voluntarily sign the informed consent form; (4) Able to use a smartphone and WeChat. 4. Primary family caregivers: (1) Aged 18 or above, without severe visual or hearing impairments; (2) Have substantial decision-making participation in family health management; (3) Able to read and proficiently use a smartphone; (4) Fully understand the study content and voluntarily participate.
Exclusion criteria
Exclusion criteria: 1. (Qualitative) Patients: (1) Living alone or without primary caregiver support; (2) With severe comorbidities, such as heart, liver, kidney dysfunction, or other malignancies; (3) Experiencing edema due to malnutrition, heart or kidney dysfunction, etc.; (4) History of surgery on the affected limb within the past year; (5) Having cognitive impairment or mental illness; (6) Expected survival less than 6 months; (7) Participating in other intervention studies on the same topic concurrently. 2. Family members: (1) Health professionals in related fields; (2) Suffering from major illnesses, such as malignancies or severe mental disorders. 3. (Intervention) Patients: (1) With other malignant tumors or severe dysfunction of the heart, liver, or kidneys; (2) Severe cognitive impairment or mental illness; (3) Concurrent participation in other intervention studies; (4) Living alone or without primary caregiver support; (5) History of other surgeries on the affected limb within the past year. 4. Primary family caregivers: (1) Professional medical personnel in the relevant field; (2) Suffering from major diseases themselves; (3) Planning to be away for an extended period in the next 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Family adaptation of BCRL patients; | — |
Secondary
| Measure | Time frame |
|---|---|
| Self-management compliance of BCRL patients;The quality of life of BCRL patients; | — |
Countries
China
Contacts
Jiangsu Cancer Hospital